An Assessment of the Material Measurement Laboratory at the National Institute of Standards and Technology Fiscal Year 2023 (2023) / Chapter Skim
Currently Skimming:

4 Biosystems and Biomaterials Division
Pages 23-29

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 23...
... They have developed 22 standards and reference materials and received 4 patents, with 3 additional applications filed. ASSESSMENT OF TECHNICAL PROGRAMS Accomplishments The division is currently divided into four main research areas: regenerative medicine and advanced therapies, precision medicine, engineering biology, and microbial metrology.
Read the entire page →
From page 24...
... , including the development of a common biotechnology genome editing vocabulary to improve communication between stakeholders. They oversee the Genome Editing, Flow Cytometry Standards, and Rapid Microbial Testing Methods consortia.
Read the entire page →
From page 25...
... In precision medicine, expertise has focused on supporting the identification, validation, and accurate measurement of biomarkers, especially for cancer diagnosis and treatment. Expertise in the Microbial Metrology Group allows the researchers to provide complex reference materials and measurement capabilities to support a wide range of industrial activities, including microbial therapeutics to treat disease, soil probiotics that enable more robust agricultural processes, novel approaches to biofuel production, and bioremediation and carbon capture for the 2 Mpox is the new name for monkeypox.
Read the entire page →
From page 26...
... Since 2020, the groups in Biosystems and Biomaterials Division continue to grow in national prominence in the areas of both mammalian and microbial biologics. During this review period, the division's programs have supported the development of the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy (Executive Order 14081)
Read the entire page →
From page 27...
... During this review period, the Biosystems and Biomaterials Division's programs have supported the development of standards related to COVID-19 and Mpox outbreaks, the development of the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy (Executive Order 14081) , the National Biodefense Strategy, and associated research and development strategy documents.
Read the entire page →
From page 28...
... The division has actively engaged the industrial community and others through 22 workshops, 91 cooperative research and development agreements, and almost 60 material and data transfer agreements. They also participate actively in four consortia, including the Flow Cytometry Standards Consortium and the NIST Rapid Microbial Testing Methods Consortium that was launched in June 2020.
Read the entire page →
From page 29...
... BIOSYSTEMS AND BIOMATERIALS DIVISION 29 across broader geographic areas of the United States to further promote the dissemination of the division's products and capabilities. Such broader geographic outreach is particularly important to reach more stakeholders involved in the growing number of bioeconomy initiatives.
Read the entire page →

Key Terms

  • reference materials
  • microbial metrology
  • advanced therapies
  • regenerative medicine
  • precision medicine

  • engineering biology
  • review period
  • flow cytometry
  • rapid microbial
  • microbial testing

  • cytometry standards
  • testing methods
  • executive order
  • standard reference
  • genome editing

  • evaluation tool
  • reference data
  • reference material
  • measurement science
  • material measurement

  • national biodefense
  • main research
  • iso standards
  • associated research
  • research teams

  • measurement laboratory
  • development strategy
  • past review
  • cell lines
  • cancer biomarker


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.